Tiroid Cerrahisi Miyokard Hasarı için Risk Taşır Mı?

Perioperatif miyokard hasarı (PMI), perioperatif morbidite ve mortalite ile ilişkili en sık görülen vasküler komplikasyondur. Çalışmamızda perioperatif dönemde tiroid cerrahisinin miyokard biyobelirteçleri üzerindeki etkisini araştırmayı amaçladık. Gereç ve Yöntemler: Çalışmamız prospektif olarak planlandı. Çalışmaya 98 hasta (%82,6 kadın, ortalama yaş =51,1±15,8 yıl) dahil edildi. Daha önce kalp hastalığı öyküsü olan hastalar çalışma dışı bırakıldı. Preoperatif, postoperatif 6. saat ve 24. saat kardiyak troponin-I, kreatin kinaz (CK)-MB ve CK düzeyleri belirlendi, her hasta için elektrokardiyografi (EKG) yapıldı. Bu üç ayrı zamandaki veriler birbirleri ile karşılaştırıldı. Bulgular: Tiroid cerrahisi uygulanan hastaların troponin-I, CK-MB, CK düzeyleri ve EKG incelemeleri yapıldı. Ameliyat sonrası 6. saatte CK düzeyleri preoperatif dönemle karşılaştırıldığında anlamlı olarak artarken, ameliyat sonrası 24. saatte hafif düştü (p

Is Thyroid Surgery A Risk for Myocardial Injury?

Objective: Thyroid surgery is a widely performed non-cardiac surgical procedure. However, peri-operative myocardial injury (PMI) is the most common vascular complication associated with poor peri-operative outcomes. We aimed to investigate the effect of thyroid surgery on myocardial biomarkers during the peri-operative period.Materials and Methods: A total of 98 patients (82.6% female, mean age=51.1±15.8 years) were prospectively included in the study. Patients with a previous history of cardiac diseases were excluded. Cardiac Troponin-I, creatine kinase (CK)-MB and CK levels were measured in the pre-operative period and at the 6th and 24th hours of the post-operative period. Furthermore, electrocardiography (ECG) was performed on each patient. Subsequently, the data collected at these three time points were compared.Results: Troponin-I, CK-MB, CK levels and ECG analysis of the patients who underwent thyroid surgery. The CK levels significantly increased in the post-operative 6th hour and slightly decreased in the post-operative 24th hour (p

PDF

___

1. Puelacher C, Lurati Buse G, Seeberger D, Sazgary L, Marbot S, Lampart A, et al. Perioperative myocardial injury after noncardiac surgery: Incidence, Mortality, and Characterization. Circulation 2018; 137: 1221-32.
2. Ekeloef S, Alamili M, Devereaux PJ, Gögenur I. Troponin elevations after non-cardiac, non-vascular surgery are predictive of major adverse cardiac events and mortality: a systematic review and meta-analysis. Br J Anaesth 2016; 117: 559-68.
3. Mauermann E, Puelacher C, Lurati Buse G. Myocardial injury after noncardiac surgery: an underappreciated problem and current challenges. Curr Opin Anaesthesiol 2016; 29: 403-12.
4. Khan J, Alonso-Coello P, Devereaux PJ. Myocardial injury after noncardiac surgery. Curr Opin Cardiol 2014; 29: 307-11.
5. Gough IR, Wilkinson D. Total thyroidectomy for management of thyroid disease. World J Surg 2000; 24: 962-5.
6. Rosato L, Avenia N, Bernante P, De Palma M, Gulino G, Nasi PG, et al. Complications of thyroid surgery: analysis of a multicentric study on 14,934 patients operated on in Italy over 5 years. World J Surg 2004; 28: 271-6.
7. Akpek M, Elcik D, Kalay N, Yarlioglues M, Dogdu O, Sahin O, et al. The prognostic value of serum gamma glutamyl transferase activity on admission in patients with STEMI undergoing primary PCI. Angiology 2012; 63: 579-85.
8. Kurtul S, Sarli B, Baktir AO, Demirbas M, Saglam H, Doğan Y, et al. Neutrophil to lymphocyte ratio predicts SYNTAX score in patients with non-ST segment elevation myocardial infarction. Int Heart J 2015; 56: 18-21.
9. Vascular Events In Noncardiac Surgery Patients Cohort Evaluation (VISION) Study Investigators, Devereaux PJ, Chan MT, Alonso-Coello P, Walsh M, Berwanger O, et al. Association Between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA 2012; 307: 2295-304.
10. van Waes JA, Nathoe HM, de Graaff JC, Kemperman H, de Borst GJ, Peelen LM, et al. Myocardial injury after noncardiac surgery and its association with short-term mortality. Circulation 2013; 127: 2264-71.
11. Mair J, Dienstl F, Puschendorf B. Cardiac troponin T in the diagnosis of myocardial injury. Crit Rev Clin Lab Sci 1992; 29: 31- 57.
12. Alaour B, Liew F, Kaier TE. Cardiac Troponin - Diagnostic Problems and Impact on Cardiovascular Disease. Ann Med 2018; 50: 655- 65.
13. Tanindi A, Cemri M. Troponin elevation in conditions other than acute coronary syndromes. Vasc Health Risk Manag 2011; 7: 597-603.